NCT03193801 - PARTNER 3 Trial - Mitral Valve in Valve | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 1, 2018

Primary Completion Date

August 16, 2022

Study Completion Date

August 31, 2031

Conditions

Mitral Valve InsufficiencyMitral Valve DiseaseMitral Valve RegurgitationHeart Failure

Interventions

DEVICE

Edwards SAPIEN 3 transcatheter valve, Model 9600TFX

Edwards SAPIEN 3 THV system Model 9600TFX with the associated delivery systems.

Trial Locations (12)

The Prince Charles Hospital, Chermside

NYU Lagone Medical Center, New York

Emory University, Atlanta

Mayo Clinic, Rochester

Northshore University Health System Research Institution, Evanston

Northwestern University, Chicago

Barnes-Jewish Hospital/ Washington University, St Louis

The Heart Hospital of Baylor Plano, Plano

Providence Heart & Vascular Institution, Portland

Brigham and Women's Hospital, Boston

Instituto do Coração da Universidade de São Paulo, Cerqueira César

Instituto Dante Pazzanese de Cardiologia, Vila Mariana